Reports for FRESENIUS KABI CANADA LTD

Company Name

FRESENIUS KABI CANADA LTD

Totals

Shortage reports

307

Actual shortage: 12 (4%)
Anticipated shortage: 1 (0%)
Avoided shortage: 5 (2%)
Resolved: 289 (94%)

Discontinuation Reports

0

To be discontinued: 0
Discontinued: 0
Reversed: 0

Late reports

48 (16%)

Overdue reports

5 (38%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SODIUM CHLORIDE INJECTION, USP 234MG SOLUTION Actual shortage 2024-03-06 2024-03-06 221460
LINEZOLID INJECTION 2MG SOLUTION Resolved 2024-03-19 2024-04-22 222722
ADENOSINE INJECTION 3MG SOLUTION Actual shortage 2024-03-19 2024-04-01 222725
MOXIFLOXACIN INJECTION 400MG SOLUTION Actual shortage 2024-04-04 2024-05-02 224325
OXYTOCIN INJECTION, USP 10UNIT SOLUTION Actual shortage 2024-04-17 2024-04-26 225346
AMPICILLIN FOR INJECTION, USP 250MG POWDER FOR SOLUTION Actual shortage 2024-04-29 2024-04-29 226471
PENICILLIN G SODIUM FOR INJECTION, USP 10000000UNIT POWDER FOR SOLUTION Anticipated shortage 2024-04-29 2024-04-29 226550

Showing 301 to 307 of 307

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports

Showing 1 to 0 of 0